Exciting times for neuromodulators on the horizon

WAIKOLOA, Hawaii — This year and the next will be very exciting for new toxins and fillers on the market, according to Charles M. Boyd, MD, MBA, FACS, at Hawaiian Eye 2019.
Restylane Kysse (Galderma) just completed FDA trials and is specifically designed for use in the lips.
The hyaluronic acid filler has a consistency between Refyne and Defyne, he said.
Teosyal (Teoxane) was FDA approved in late 2017 and is expected to be available in the US in 2019.
“The hyaluronic acid filler is designed to stretch with the (Read more...)

Full Story →